Literature DB >> 14562575

Gastrointestinal manifestations of mitochondrial disease.

Lynette A Gillis1, Ronald J Sokol.   

Abstract

Although non-specific gastrointestinal and hepatic symptoms are commonly found in most mitochondrial disorders, they are among the cardinal manifestations of several primary mitochondrial diseases, such as: mitochondrial neurogastrointestinal encephalomyopathy; mitochondrial DNA depletion syndrome; Alpers syndrome; and Pearson syndrome. Management of these heterogeneous disorders includes the empiric supplementation with various "mitochondrial cocktails," supportive therapies, and avoidance of drugs and conditions known to have a detrimental effect on the respiratory chain. There is a great need for improved methods of treatment and controlled clinical trials of existing therapies. Liver transplantation is successful in acquired cases; however neuromuscular involvement in primary mitochondrial disorders should be a contraindication for liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14562575     DOI: 10.1016/s0889-8553(03)00052-9

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

1.  Mitochondrial neuro-gastrointestinal encephalopathy syndrome.

Authors:  Anuj Walia; B R Thapa; V Kim
Journal:  Indian J Pediatr       Date:  2006-12       Impact factor: 1.967

2.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

3.  A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes.

Authors:  Bulent Kurt; Jaak Jaeken; Johan Van Hove; Lieven Lagae; Ann Löfgren; David B Everman; Parul Jayakar; Ali Naini; Klaas J Wierenga; Gert Van Goethem; William C Copeland; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2010-02

Review 4.  Presentation and diagnosis of mitochondrial disorders in children.

Authors:  Mary Kay Koenig
Journal:  Pediatr Neurol       Date:  2008-05       Impact factor: 3.372

Review 5.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 6.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

Review 7.  Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.

Authors:  Deborah E Meyers; Haseeb Ilias Basha; Mary Kay Koenig
Journal:  Tex Heart Inst J       Date:  2013

8.  Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone.

Authors:  N L Julie; I M Julie; A I Kende; G L Wilson
Journal:  Diabetologia       Date:  2008-08-23       Impact factor: 10.122

9.  Hepatocerebral form of mitochondrial DNA depletion syndrome due to mutation in MPV17 gene.

Authors:  Abdulaziz AlSaman; Hoda Tomoum; Federica Invernizzi; Massimo Zeviani
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

Review 10.  Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson's Disease.

Authors:  Mesfer Al Shahrani; Simon Heales; Iain Hargreaves; Michael Orford
Journal:  J Clin Med       Date:  2017-10-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.